Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma Glioblastoma Multiforme”

2,113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,113 results

Not applicableNot Yet RecruitingNCT07029100
What this trial is testing

Feasibility of ORGAnoids in Routine Clinical Practice for Molecular Analysis of the GLIOvascular Niche in Patients With Primary Brain Tumors.

Who this might be right for
Glioblastoma
Centre Henri Becquerel 30
Early research (Phase 1)Looking for participantsNCT06389591
What this trial is testing

RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)

Who this might be right for
Recurrent Glioblastoma
University of Florida 24
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Study completedNCT01294735
What this trial is testing

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19
Not applicableStudy completedNCT00463008
What this trial is testing

Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 12
Early research (Phase 1)WithdrawnNCT01189513
What this trial is testing

SCH-900105 in Recurrent Glioblastoma

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02335918
What this trial is testing

A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)Ovarian Carcinoma-Enrollment CompletedColorectal Cancer (CRC)-Enrollment Completed+2 more
Celldex Therapeutics 175
Testing effectiveness (Phase 2)Study completedNCT00082797
What this trial is testing

High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Eastern Cooperative Oncology Group 36
Very early researchLooking for participantsNCT07387666
What this trial is testing

Imaging Acetadote Metabolism in Glioblastoma

Who this might be right for
GlioblastomaGBM
University of Texas Southwestern Medical Center 10
Very early researchStudy completedNCT00743353
What this trial is testing

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

Who this might be right for
SarcomaMelanomaLung Cancer+2 more
Siemens Molecular Imaging 16
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)Study completedNCT00694837
What this trial is testing

Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma

Who this might be right for
Glioblastoma
Maastricht Radiation Oncology 6
Early research (Phase 1)Study completedNCT01222221
What this trial is testing

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT03395587
What this trial is testing

Efficiency of Vaccination with Lysate-loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Heinrich-Heine University, Duesseldorf 136
Early research (Phase 1)Study completedNCT00089427
What this trial is testing

IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma
INSYS Therapeutics Inc 24
Testing effectiveness (Phase 2)Study completedNCT04013672
What this trial is testing

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Who this might be right for
Recurrent Glioblastoma
David Peereboom 41
Not applicableActive Not RecruitingNCT03181477
What this trial is testing

Study Evaluating the Efficacy of Radiotherapy With SIB-IMRT, Associated With Temozolomide in Glioblastomas

Who this might be right for
Glioblastoma, Adult
Centre Georges Francois Leclerc 67
Testing effectiveness (Phase 2)Ended earlyNCT01721577
What this trial is testing

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more
Rush University Medical Center 10
Not applicableEnded earlyNCT02329795
What this trial is testing

Image-derived Prediction of Response to Chemo-radiation in Glioblastoma

Who this might be right for
Glioblastoma
Rigshospitalet, Denmark 16
Testing effectiveness (Phase 2)UnknownNCT05447195
What this trial is testing

Phase 2 Study of CAN008 in Subjects With GBM

Who this might be right for
Newly-diagnosed Glioblastoma
CANbridge Life Sciences Ltd. 117
Next Page